Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-06

FDA Approved: ESTAZOLAM — Supplemental Application (Novitium Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for ESTAZOLAM (Estazolam) by Novitium Pharma LLC under an ANDA, authorizing changes to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estazolam (Estazolam)

Snippet

SUPPL AP for ESTAZOLAM (ESTAZOLAM)